A 28.69% Upside Potential Lures Investors Amidst Strong Dividend Yield
Pfizer, Inc. (NYSE: PFE), a stalwart in the healthcare sector, continues to command attention with its diverse portfolio of biopharmaceutical products and a market cap of $129.99 billion. As one of the leading figures in the general drug manufacturing industry, Pfizer’s current stock price stands at $22.92, reflecting a modest price change of 0.14 USD or 0.01% recently. This price is nestled within a 52-week range of $21.59 to $31.39, suggesting both potential stability and volatility, which could intrigue both conservative and speculative investors.
One of the most compelling aspects of Pfizer’s investment proposition is its dividend yield, which stands at an impressive 7.50%. However, it’s important to note that the payout…
